CIDRAP newsletters options
In its latest weekly FluView report today, the US Centers for Disease Control and Prevention (CDC) said it has received reports of nine more variant H3N2 (H3N2v) influenza cases, eight from Maryland and one from Michigan, its first of the year.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Syria has confirmed seven new cases involving vaccine-derived poliovirus 2 (cVDPV2) infection and Pakistan has reported four detections of wild poliovirus 1 (WPV1) in environmental samples, the Global Polio Eradication Initiative (GPEI) said today in its weekly update.
The observational study found 46% protection but is smaller than an earlier one that showed no protection.
Varied efforts involve states, cities, food buyers, and hospital groups.
Tillerson voices support for US collaboration on global infectious disease issues, including those involving HIV and malaria.
Iranian scientists report a 7.6% prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in almost 500 hospital food samples they tested, and the bacteria had high levels of resistance to other antibiotics, as well, according to a study yesterday in Antimicrobial Resistance & Infection Control.
Comprehensive biomedical research must continue its crucial role in preparing the world for the next pandemic or other far-reaching public health emergency, whether it be caused by a novel influenza strain, Ebola, or some other transmissible pathogen, Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID) and colleagues wrote in a commentary in the Journal
In one case, relying on ultrasound alone would have given the mother false assurance.
The trial of 40 adults with 2 dose levels found the vaccine safe and immunogenic.
A potential new weapon to fight multidrug-resistant bacteria comes in a very, very small package.
California researchers have developed a rapid test to detect antibiotic susceptibility in urinary tract infections (UTIs) in less than 30 minutes, which could allow patients to be diagnosed and prescribed effective antibiotics during just one healthcare visit, according to a study today in Science Translational Medicine.
Neutralizing monoclonal antibodies engineered from three humans infected with Zika virus protected non-human primates from contracting the mosquito-borne disease, according to a new study published in Science Translational Medicine.
Six main strategies target disease in hot spot countries that drive much of the world's cholera activity.
Scientists manipulate mosquitoes' abilities to host the parasite Plasmodium falciparum.
The Saudi Arabian Ministry of Health (MOH) announced a new case of MERS-CoV today.
The patient is a 72-year-old man from Tabuk, a city in northwestern Saudi Arabia near the Jordanian border. He presented with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus) infection and is in stable condition. The man had direct contact with camels, a known risk factor for contracting MERS.
Investigators found rising nonsusceptibility in E coli isolates, but decreasing resistance in other gram-negative pathogens.
The $170.2 million in BioShield funds covers late-stage development and buys up to 1.13 million vaccine regimens and an unspecified number of treatment courses of two Ebola drugs.
After a lag in reporting last week, the Saudi Arabian Ministry of Health (MOH) updated it information on MERS-CoV cases over the weekend, noting three new cases since the agency last reported on Sep 25.
The US total of H3N2v cases would rise to 50 if CDC tests confirm 18 Maryland presumed positives.
